Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Ventana Symphony Users(?)

Council Members in this Study Group: 17

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Stan Schofield, MS, MHA,MT(ASCP), Managing Principal, The Compass Group, ScarboroughStan Schofield, MS, MHA,MT(ASCP)
Managing Principal
The Compass Group, Scarborough

Stan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a Vice President and senior member of the health system executive management team. Mr. Schofield is the Managing Principal of the Compass Group, a...

Joseph Schappert, MD
Medical Director
Icon Central Laboratories, Inc.

Joseph Schappert, MD, is the Medical Director at ICON Laboratories, Inc. in New York. He is involved in innovative and state-of-art information technology, flow cytometric and molecular diagnostic solutions in support of clinical trials conducted worldwide. Previously, Dr. Schappert was the Vice Chair...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Novel molecules and diagnostic tests | 02-19-2008
Analysis of: Kidney Cancer Drug Linked to Higher Rate of Heart Problems | www.washingtonpost.com
Author: Joseph Schappert, MD, Medical Director , Icon Central Laboratories, Inc.

Diagnostic tools are availible to identify these adverse effects at an early stage in their clinical development. These tools should mitigate the seriousness of these adverse events.

Microrganisms elude our control | 03-05-2007
Author: Joseph Schappert, MD, Medical Director , Icon Central Laboratories, Inc.

Our experience with antibiotics has consistently shown that resistance occurs within 3-5 years of their widespread utilization. Our more recent experience with antiviral agents has been similar. Without diminishing the important role that antimicrobials have played in our recent history, it has also...

The future of clinical laboratory diagnostics | 03-05-2007
Author: Joseph Schappert, MD, Medical Director , Icon Central Laboratories, Inc.

The purchase of Abbott Diagnostics (ADD) by General Electric follows the purchase of Bayer Diagnostics and DPC by Siemens. It can be anticipated that GE will purchase a second diagnostics company. Since this is part of a restructuring of the diagnostics industry away from pharmaceutical companies to...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Laboratory, Independent
  • Contract Research Organization, Large
  • Facility, Academic Medical Center
  • Lab, Academic Medical Center
  • Medical Device Manufacturer
  • Non-Academic Community Hospital or Clinic
  • Professional or Industry Association*

Most Common Job Types:

  • Physician - Attending Physician
  • Director
  • Physician - Department Chair
  • Physician - Director
  • Principal
  • Consultant
  • President
  • Research Scientist
  • Technician

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-04T21:45:18.380